APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant FVIII

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant FVIII Industry Growth and Trends Forecast to 2032

31 December 202590 pages

Choose your research edition.

Industry ResearchRecombinant FVIII Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant FVIII Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Recombinant FVIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant FVIII Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant FVIII Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Recombinant FVIII market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant FVIII is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant FVIII is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant FVIII is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant FVIII include Sinocelltech, Comirnaty, Novo Nordisk, Green Cross, Bayer and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant FVIII market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant FVIII market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant FVIII market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant FVIII.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant FVIII market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant FVIII Market by Company

Sinocelltech

Comirnaty

Novo Nordisk

Green Cross

Bayer

Baxter

Recombinant FVIII Segment by Type

1000 IU/bottle

2000 IU/bottle

250 IU/bottle

500 IU/bottle

Recombinant FVIII Segment by Application

Teenagers

Adults

Recombinant FVIII Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant FVIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant FVIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant FVIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant FVIII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant FVIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1000 IU/bottle Table 2. Major Company of 2000 IU/bottle Table 3. Major Company of 250 IU/bottle Table 4. Major Company of 500 IU/bottle Table 5. Global Recombinant FVIII Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 7. Global Recombinant FVIII Sales Market Share in Volume by Type (2021-2026) Table 8. Global Recombinant FVIII Sales by Type (2021-2026) & (US$ Million) Table 9. Global Recombinant FVIII Sales Market Share in Value by Type (2021-2026) Table 10. Global Recombinant FVIII Price by Type (2021-2026) & (US$/Unit) Table 11. Global Recombinant FVIII Sales by Type (2027-2032) & (K Units) Table 12. Global Recombinant FVIII Sales Market Share in Volume by Type (2027-2032) Table 13. Global Recombinant FVIII Sales by Type (2027-2032) & (US$ Million) Table 14. Global Recombinant FVIII Sales Market Share in Value by Type (2027-2032) Table 15. Global Recombinant FVIII Price by Type (2027-2032) & (US$/Unit) Table 16. North America Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 17. North America Recombinant FVIII Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 19. Europe Recombinant FVIII Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Recombinant FVIII Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 23. Latin America Recombinant FVIII Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Recombinant FVIII Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Recombinant FVIII Sales by Type (2021-2026) & (US$ Million) Table 26. Recombinant FVIII Industry Trends Table 27. Recombinant FVIII Industry Drivers Table 28. Recombinant FVIII Industry Opportunities and Challenges Table 29. Recombinant FVIII Industry Restraints Table 30. Global Recombinant FVIII Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Recombinant FVIII Revenue Market Share by Company (2021-2026) Table 32. Global Recombinant FVIII Sales by Company (2021-2026) & (K Units) Table 33. Global Recombinant FVIII Sales Share by Company (2021-2026) Table 34. Global Recombinant FVIII Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Recombinant FVIII Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Recombinant FVIII Major Company Production Sites and Headquarters Table 37. Global Recombinant FVIII Company, Product Type & Application Table 38. Global Recombinant FVIII Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Recombinant FVIII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Recombinant FVIII Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Recombinant FVIII Sales by Region (2021-2026) & (K Units) Table 43. Global Recombinant FVIII Sales Market Share in Volume by Region (2021-2026) Table 44. Global Recombinant FVIII Sales by Region (2021-2026) & (US$ Million) Table 45. Global Recombinant FVIII Sales Market Share in Value by Region (2021-2026) Table 46. Global Recombinant FVIII Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Recombinant FVIII Sales by Region (2027-2032) & (K Units) Table 48. Global Recombinant FVIII Sales Market Share in Volume by Region (2027-2032) Table 49. Global Recombinant FVIII Sales by Region (2027-2032) & (US$ Million) Table 50. Global Recombinant FVIII Sales Market Share in Value by Region (2027-2032) Table 51. Global Recombinant FVIII Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Recombinant FVIII Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 54. Global Recombinant FVIII Sales Market Share in Volume by Application (2021-2026) Table 55. Global Recombinant FVIII Sales by Application (2021-2026) & (US$ Million) Table 56. Global Recombinant FVIII Sales Market Share in Value by Application (2021-2026) Table 57. Global Recombinant FVIII Price by Application (2021-2026) & (US$/Unit) Table 58. Global Recombinant FVIII Sales by Application (2027-2032) & (K Units) Table 59. Global Recombinant FVIII Sales Market Share in Volume by Application (2027-2032) Table 60. Global Recombinant FVIII Sales by Application (2027-2032) & (US$ Million) Table 61. Global Recombinant FVIII Sales Market Share in Value by Application (2027-2032) Table 62. Global Recombinant FVIII Price by Application (2027-2032) & (US$/Unit) Table 63. North America Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 64. North America Recombinant FVIII Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 66. Europe Recombinant FVIII Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Recombinant FVIII Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 70. Latin America Recombinant FVIII Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Recombinant FVIII Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Recombinant FVIII Sales by Application (2021-2026) & (US$ Million) Table 73. Sinocelltech Company Information Table 74. Sinocelltech Business Overview Table 75. Sinocelltech Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sinocelltech Recombinant FVIII Product Portfolio Table 77. Sinocelltech Recent Development Table 78. Comirnaty Company Information Table 79. Comirnaty Business Overview Table 80. Comirnaty Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Comirnaty Recombinant FVIII Product Portfolio Table 82. Comirnaty Recent Development Table 83. Novo Nordisk Company Information Table 84. Novo Nordisk Business Overview Table 85. Novo Nordisk Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novo Nordisk Recombinant FVIII Product Portfolio Table 87. Novo Nordisk Recent Development Table 88. Green Cross Company Information Table 89. Green Cross Business Overview Table 90. Green Cross Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Green Cross Recombinant FVIII Product Portfolio Table 92. Green Cross Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Bayer Recombinant FVIII Product Portfolio Table 97. Bayer Recent Development Table 98. Baxter Company Information Table 99. Baxter Business Overview Table 100. Baxter Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Baxter Recombinant FVIII Product Portfolio Table 102. Baxter Recent Development Table 103. North America Recombinant FVIII Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 105. North America Recombinant FVIII Sales Market Share by Country (2021-2026) Table 106. North America Recombinant FVIII Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Recombinant FVIII Sales Market Share Forecast by Country (2027-2032) Table 108. North America Recombinant FVIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Recombinant FVIII Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Recombinant FVIII Market Share by Country (2021-2026) Table 111. North America Recombinant FVIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Recombinant FVIII Market Share Forecast by Country (2027-2032) Table 113. Europe Recombinant FVIII Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 115. Europe Recombinant FVIII Sales Market Share by Country (2021-2026) Table 116. Europe Recombinant FVIII Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Recombinant FVIII Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Recombinant FVIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Recombinant FVIII Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Recombinant FVIII Market Share by Country (2021-2026) Table 121. Europe Recombinant FVIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Recombinant FVIII Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Recombinant FVIII Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Recombinant FVIII Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Recombinant FVIII Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Recombinant FVIII Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Recombinant FVIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Recombinant FVIII Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Recombinant FVIII Market Share by Country (2021-2026) Table 131. Asia-Pacific Recombinant FVIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Recombinant FVIII Market Share Forecast by Country (2027-2032) Table 133. Latin America Recombinant FVIII Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 135. Latin America Recombinant FVIII Sales Market Share by Country (2021-2026) Table 136. Latin America Recombinant FVIII Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Recombinant FVIII Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Recombinant FVIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Recombinant FVIII Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Recombinant FVIII Market Share by Country (2021-2026) Table 141. Latin America Recombinant FVIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Recombinant FVIII Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Recombinant FVIII Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Recombinant FVIII Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Recombinant FVIII Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Recombinant FVIII Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Recombinant FVIII Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Recombinant FVIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Recombinant FVIII Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Recombinant FVIII Market Share by Country (2021-2026) Table 151. Middle East and Africa Recombinant FVIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Recombinant FVIII Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Recombinant FVIII Distributors List Table 156. Recombinant FVIII Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Recombinant FVIII Image Figure 2. Global Recombinant FVIII Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant FVIII Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant FVIII Sales (2021-2032) & (K Units) Figure 5. 1000 IU/bottle Image Figure 6. Global 1000 IU/bottle Sales YoY Growth (2021-2032) & (K Units) Figure 7. 2000 IU/bottle Image Figure 8. Global 2000 IU/bottle Sales YoY Growth (2021-2032) & (K Units) Figure 9. 250 IU/bottle Image Figure 10. Global 250 IU/bottle Sales YoY Growth (2021-2032) & (K Units) Figure 11. 500 IU/bottle Image Figure 12. Global 500 IU/bottle Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Recombinant FVIII Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Recombinant FVIII Market Share by Type 2025 VS 2032 Figure 15. North America Recombinant FVIII Sales Market Share in Volume by Type in 2025 Figure 16. North America Recombinant FVIII Sales Market Share in Value by Type in 2025 Figure 17. Europe Recombinant FVIII Sales Market Share in Volume by Type in 2025 Figure 18. Europe Recombinant FVIII Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Recombinant FVIII Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Recombinant FVIII Sales Market Share in Value by Type in 2025 Figure 21. Latin America Recombinant FVIII Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Recombinant FVIII Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Recombinant FVIII Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Recombinant FVIII Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Recombinant FVIII Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Teenagers Image Figure 28. Global Teenagers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Adults Image Figure 30. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Recombinant FVIII Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Recombinant FVIII Market Share by Application 2025 VS 2032 Figure 33. North America Recombinant FVIII Sales Market Share in Volume by Application in 2025 Figure 34. North America Recombinant FVIII Sales Market Share in Value by Application in 2025 Figure 35. Europe Recombinant FVIII Sales Market Share in Volume by Application in 2025 Figure 36. Europe Recombinant FVIII Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Recombinant FVIII Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Recombinant FVIII Sales Market Share in Value by Application in 2025 Figure 39. Latin America Recombinant FVIII Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Recombinant FVIII Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Recombinant FVIII Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Recombinant FVIII Sales Market Share in Value by Application in 2025 Figure 43. North America Recombinant FVIII Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Recombinant FVIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Recombinant FVIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Recombinant FVIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant FVIII Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Recombinant FVIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Recombinant FVIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Recombinant FVIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant FVIII Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Recombinant FVIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Recombinant FVIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Recombinant FVIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant FVIII Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Recombinant FVIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Recombinant FVIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Recombinant FVIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant FVIII Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Recombinant FVIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Recombinant FVIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Recombinant FVIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Recombinant FVIII Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Recombinant FVIII Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1000 IU/bottle
  • 2000 IU/bottle
  • 250 IU/bottle
  • 500 IU/bottle
Applications
  • Teenagers
  • Adults
Companies covered
  • Sinocelltech
  • Comirnaty
  • Novo Nordisk
  • Green Cross
  • Bayer
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant FVIII Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant FVIII Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant FVIII Market by Type
  6. 1.3.1 1000 IU/bottle
  7. 1.3.2 2000 IU/bottle
  8. 1.3.3 250 IU/bottle
  9. 1.3.4 500 IU/bottle
  10. 1.4 Global Recombinant FVIII Market Size by Type
  11. 1.4.1 Global Recombinant FVIII Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Recombinant FVIII Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Recombinant FVIII Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Recombinant FVIII Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Recombinant FVIII Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Recombinant FVIII Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Recombinant FVIII Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Recombinant FVIII Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant FVIII Industry Trends
  2. 2.2 Recombinant FVIII Industry Drivers
  3. 2.3 Recombinant FVIII Industry Opportunities and Challenges
  4. 2.4 Recombinant FVIII Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant FVIII Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant FVIII Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant FVIII Price (2021-2026)
  4. 3.4 Global Recombinant FVIII Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant FVIII Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant FVIII Company, Product Type & Application
  7. 3.7 Global Recombinant FVIII Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant FVIII Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant FVIII Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant FVIII Tier 1, Tier 2, and Tier 3
4 Recombinant FVIII Regional Status and Outlook
  1. 4.1 Global Recombinant FVIII Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant FVIII Historic Market Size by Region
  3. 4.2.1 Global Recombinant FVIII Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant FVIII Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant FVIII Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant FVIII Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant FVIII Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant FVIII Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant FVIII Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant FVIII by Application
  1. 5.1 Recombinant FVIII Market by Application
  2. 5.1.1 Teenagers
  3. 5.1.2 Adults
  4. 5.2 Global Recombinant FVIII Market Size by Application
  5. 5.2.1 Global Recombinant FVIII Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant FVIII Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant FVIII Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant FVIII Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant FVIII Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant FVIII Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant FVIII Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant FVIII Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sinocelltech
  2. 6.1.1 Sinocelltech Company Information
  3. 6.1.2 Sinocelltech Business Overview
  4. 6.1.3 Sinocelltech Recombinant FVIII Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sinocelltech Recombinant FVIII Product Portfolio
  6. 6.1.5 Sinocelltech Recent Developments
  7. 6.2 Comirnaty
  8. 6.2.1 Comirnaty Company Information
  9. 6.2.2 Comirnaty Business Overview
  10. 6.2.3 Comirnaty Recombinant FVIII Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Comirnaty Recombinant FVIII Product Portfolio
  12. 6.2.5 Comirnaty Recent Developments
  13. 6.3 Novo Nordisk
  14. 6.3.1 Novo Nordisk Company Information
  15. 6.3.2 Novo Nordisk Business Overview
  16. 6.3.3 Novo Nordisk Recombinant FVIII Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novo Nordisk Recombinant FVIII Product Portfolio
  18. 6.3.5 Novo Nordisk Recent Developments
  19. 6.4 Green Cross
  20. 6.4.1 Green Cross Company Information
  21. 6.4.2 Green Cross Business Overview
  22. 6.4.3 Green Cross Recombinant FVIII Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Green Cross Recombinant FVIII Product Portfolio
  24. 6.4.5 Green Cross Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Recombinant FVIII Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Recombinant FVIII Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Recombinant FVIII Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Recombinant FVIII Product Portfolio
  36. 6.6.5 Baxter Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant FVIII Sales by Country
  2. 7.1.1 North America Recombinant FVIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant FVIII Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant FVIII Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant FVIII Market Size by Country
  6. 7.2.1 North America Recombinant FVIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant FVIII Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant FVIII Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant FVIII Sales by Country
  2. 8.1.1 Europe Recombinant FVIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant FVIII Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant FVIII Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant FVIII Market Size by Country
  6. 8.2.1 Europe Recombinant FVIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant FVIII Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant FVIII Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant FVIII Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant FVIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant FVIII Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant FVIII Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant FVIII Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant FVIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant FVIII Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant FVIII Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant FVIII Sales by Country
  2. 10.1.1 South America Recombinant FVIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant FVIII Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant FVIII Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant FVIII Market Size by Country
  6. 10.2.1 South America Recombinant FVIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant FVIII Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant FVIII Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant FVIII Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant FVIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant FVIII Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant FVIII Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant FVIII Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant FVIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant FVIII Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant FVIII Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant FVIII Value Chain Analysis
  2. 12.1.1 Recombinant FVIII Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant FVIII Production Mode & Process
  7. 12.2 Recombinant FVIII Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant FVIII Distributors
  10. 12.2.3 Recombinant FVIII Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst